Studies show Depo-Provera users have much higher relative risk of developing meningiomas, although overall risk remains low ...
A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...
Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.
The MarketWatch News Department was not involved in the creation of this content. The number of lawsuits filed has tripled to over 1300 since May New US peer-reviewed study adds to body of research ...
PENSACOLA, Fla.--(BUSINESS WIRE)-- At a Case Management Conference in the Multi District Litigation against Pfizer Inc., the Honorable M. Casey Rodgers set a date for the first Trial, which will take ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results